Sensorion SA (ALSEN) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.332x

Based on the latest financial reports, Sensorion SA (ALSEN) has a cash flow conversion efficiency ratio of -0.332x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-18.94 Million ≈ $-22.14 Million USD) by net assets (€56.98 Million ≈ $66.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Sensorion SA's balance sheet to measure how much of total assets are equity-financed.

Sensorion SA - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Sensorion SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ALSEN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Sensorion SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sensorion SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dollar Industries Limited NSE:DOLLAR	0.049x
Mechema Chemicals Int TWO:4721	0.108x
RADCOM Ltd F:RAM	N/A
Site Centers Corp NYSE:SITC	-0.013x
Atlan Holdings Bhd KLSE:7048	0.149x
PBA Holdings Bhd KLSE:5041	0.032x
Aurora Cannabis Inc NASDAQ:ACB	0.030x
Gia Lai Electricity JSC VN:GEG	0.076x

Annual Cash Flow Conversion Efficiency for Sensorion SA (2012–2024)

The table below shows the annual cash flow conversion efficiency of Sensorion SA from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see ALSEN market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€72.14 Million ≈ $84.34 Million	€-21.33 Million ≈ $-24.94 Million	-0.296x	+53.30%
2023-12-31	€33.28 Million ≈ $38.90 Million	€-21.07 Million ≈ $-24.63 Million	-0.633x	+35.30%
2022-12-31	€21.87 Million ≈ $25.57 Million	€-21.41 Million ≈ $-25.02 Million	-0.979x	-299.56%
2021-12-31	€43.98 Million ≈ $51.42 Million	€-10.77 Million ≈ $-12.59 Million	-0.245x	-168.93%
2020-12-31	€58.35 Million ≈ $68.21 Million	€-5.31 Million ≈ $-6.21 Million	-0.091x	+91.51%
2019-12-31	€13.21 Million ≈ $15.45 Million	€-14.17 Million ≈ $-16.56 Million	-1.072x	+69.27%
2018-12-31	€3.51 Million ≈ $4.10 Million	€-12.25 Million ≈ $-14.32 Million	-3.489x	-228.29%
2017-12-31	€7.32 Million ≈ $8.56 Million	€-7.78 Million ≈ $-9.10 Million	-1.063x	-26.94%
2016-12-31	€8.59 Million ≈ $10.04 Million	€-7.19 Million ≈ $-8.41 Million	-0.837x	-112.45%
2015-12-31	€12.82 Million ≈ $14.99 Million	€-5.05 Million ≈ $-5.91 Million	-0.394x	-105.53%
2014-12-31	€-323.20K ≈ $-377.85K	€-2.30 Million ≈ $-2.69 Million	7.130x	+504.41%
2013-12-31	€-1.20 Million ≈ $-1.40 Million	€-1.42 Million ≈ $-1.66 Million	1.180x	+103.73%
2012-12-31	€26.11K ≈ $30.53K	€-826.03K ≈ $-965.71K	-31.636x	--

About Sensorion SA

PA:ALSEN France Biotechnology

Market Cap

$173.58 Million

€148.47 Million EUR

Market Cap Rank

#17249 Global

#255 in France

Share Price

€0.29

Change (1 day)

+3.78%

52-Week Range

€0.23 - €0.70

All Time High

€12.53